Unravelling the Impact of Bolsa Família Program on Birth Weight Indicators in Brazil

By Staff Writer

December 6, 2023

Introduction

Birth weight and gestational age are vital indicators of newborn health. Low birth weight (LBW) is a concern. Especially in low and middle-income countries, as it poses short and long-term health risks. In Brazil, approximately 8.7% of live births are considered LBW. This statistic that hasn’t significantly decreased over the last 15 years. This study examines the impact of Bolsa Família Program (BFP) on Birth Weight in Brazil, a conditional cash transfer (CCT) program in Brazil, that impacts these birth weight indicators.

Impact of Bolsa Família Program on Birth Weight in Brazil

The BFP, one of the world’s pioneering CCTs, benefits over 13 million families per year. In the 1990s, the strategy was initiated for social protection and poverty reduction. Unlike unconditional cash transfer programs that provide only monetary transfers, CCTs require adherence to a health and education agenda for continued receipt. This requirement may lead to reductions in barriers to accessing services, increased income and food access, and, consequently, promotion of maternal and child health.

The Study Population and the Exposure

The study focused on children born from live births in the Centro de Integracao de Dados e Conhecimentos Para Saude (CIDACS) Birth Cohort from 2012 to 2015. The mothers were aged between 10 and 49 years and were registered on CadÚnico, the Brazilian national social program register. The study considered births that occurred between 2012 and 2015 due to a change to birth certificates in 2011. The births were classified based on whether the mother started receiving BFP during the cohort period.

Findings

The study found that BFP participation was associated with reduced chances of LBW and an increase in birth weight in grams. The impact was greater among higher-risk population subgroups, such as mothers who attended fewer than seven antenatal care appointments, were Black, Indigenous, or Parda, and less educated. They found an association among Indigenous mothers and those with less education, where participation in BFP decreased the odds of small for gestational age. 

Conclusions

The study found an association between BFP participation and improved birth weight indicators, particularly in higher-risk groups. This highlights the importance of maintaining financial support. Especially for high-risk mothers and reducing barriers to access and use of health services. Future studies may also assess the quality of prenatal care provided to socioeconomically high-risk populations.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.